Midyear Course-Clinical Hepatology: State-of-the-Art Management:
The Liver Meeting ® 2015
AASLD TV talks to Raymond Chung, MD, Co-Chair of the revised HCV Guidance about the real world experience vs. clinical trials with medication made available to the public a year ago, as well as the new drugs expected to be approved in January of 2016.
We also talk to Norah Terrault, MD, MPH, Co-Author of the refined HBV Guidelines, about those new guidelines and the most common question she’s being asked by clinicians. #Liver15 #LiverLeader